Author

Johanna Eliasson

SAFETY AND EFFICACY OF APRAGLUTIDE IN PATIENTS WITH SHORT BOWEL SYNDROME: AN OPEN-LABEL PHASE 2 METABOLIC BALANCE TRIAL
SAFETY AND EFFICACY OF APRAGLUTIDE IN PATIENTS WITH SHORT BOWEL SYNDROME: AN OPEN-LABEL PHASE 2 METABOLIC BALANCE TRIAL

Johanna Eliasson  et al.

SAFETY AND EFFICACY OF APRAGLUTIDE IN PATIENTS WITH SHORT BOWEL SYNDROME: AN OPEN-LABEL PHASE 2 METABOLIC BALANCE TRIAL
SAFETY AND EFFICACY OF APRAGLUTIDE IN PATIENTS WITH SHORT BOWEL SYNDROME: AN OPEN-LABEL PHASE 2 METABOLIC BALANCE TRIAL

Johanna Eliasson

SAFETY AND EFFICACY OF APRAGLUTIDE IN PATIENTS WITH SHORT BOWEL SYNDROME INTESTINAL FAILURE: A DOUBLE-BLIND, CROSSOVER, RANDOMIZED, PLACEBO-CONTROLLED, PHASE 2 TRIAL
SAFETY AND EFFICACY OF APRAGLUTIDE IN PATIENTS WITH SHORT BOWEL SYNDROME INTESTINAL FAILURE: A DOUBLE-BLIND, CROSSOVER, RANDOMIZED, PLACEBO-CONTROLLED, PHASE 2 TRIAL

Johanna Eliasson  et al.

Item 1 - 3 / 3
1